EAGLE, Idaho, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Valor HospiceCare (“Valor”), which provides skilled hospice services in Tucson, Green Valley, and Sierra Vista, Arizona.
“We are pleased to expand our operations in the state of Arizona, complementing our Emblem Hospice and Agape Hospice agencies in Tucson and Green Valley, and expanding into Sierra Vista with Valor HospiceCare,” said Brent Guerisoli, Chief Executive Officer of Pennant.
“Valor has a long standing and deep connection in the communities it serves, and we are honored to carry on this progress, providing life-changing service to the residents of Tucson, Green Valley, and Sierra Vista and their surrounding communities,” added John Gochnour, President and Chief Operating Officer of Pennant.
Mr. Guerisoli reaffirmed that Pennant continues to pursue opportunities to acquire high quality home health, hospice and senior living businesses throughout the United States.
About Pennant
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 99 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Last Trade: | US$30.56 |
Daily Change: | -0.58 -1.86 |
Daily Volume: | 266,066 |
Market Cap: | US$923.160M |
November 06, 2024 November 01, 2024 September 30, 2024 August 06, 2024 August 01, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB